40.25
+0.80
+(2.03%)
At close: January 30 at 5:31:16 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Cash Flows from Used in Operating Activities Direct
146,175.00
218,276.00
231,131.00
-94,787.00
262,449.00
Financing Cash Flow
-144,090.00
-220,213.00
-233,271.00
91,768.00
-284,483.00
End Cash Position
2,407.00
501.00
1,948.00
2,835.00
6,816.00
Issuance of Capital Stock
--
--
--
9,653.00
20.00
Issuance of Debt
--
--
8,000.00
292,000.00
--
Repayment of Debt
-27,800.00
-58,100.00
--
--
-87,000.00
Repurchase of Capital Stock
-813.00
--
-27,303.00
-9,459.00
-8,260.00
Free Cash Flow
146,175.00
218,276.00
231,131.00
-94,787.00
262,449.00
12/31/2020 - 1/4/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SANN.SW Santhera Pharmaceuticals Holding AG
16.40
+7.61%
NWRN.SW Newron Pharmaceuticals S.p.A.
9.42
-0.84%
XLS.SW Xlife Sciences AG
21.10
+0.48%
IDIA.SW Idorsia Ltd
0.7155
+0.49%
XBIT XBiotech Inc.
3.6200
+0.28%
RLF.SW Relief Therapeutics Holding SA
3.7300
+2.19%
GLPG.AS Galapagos NV
22.18
-0.18%
TUB.BR Financière de Tubize SA
153.20
-0.78%
GYX.F Futura Medical plc
0.3500
+1.74%
1GDA.F Zevra Therapeutics, Inc.
7.45
0.00%